Effective treatment of steroids: A Synthesis of Findings from 6 Studies
- Home
- Effective treatment of steroids
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effective treatment of steroids: A Synthesis of Findings from 6 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Key Research Findings
A study on the effectiveness of methotrexate in treating Crohn's disease showed that methotrexate was more effective than placebo in improving symptoms and reducing the need for prednisone in patients with chronically active Crohn's disease. 1
A study on the benefits of inhaled corticosteroids in the emergency department treatment of acute asthma showed that inhaled corticosteroids reduced hospital admission rates in patients with acute asthma who were not receiving concomitant systemic steroids. In children, inhaled corticosteroids appeared to be at least as effective as systemic steroids. 2
Research on the efficacy of immunosuppressive and cytotoxic therapies for pulmonary sarcoidosis found that the current evidence supporting the use of immunosuppressive and cytotoxic therapies is limited. Side effects associated with some of these therapies were severe. 3 4
A study examining a patient education program to enhance decision autonomy in multiple sclerosis relapse management found that despite strong recommendations for high-dose intravenous corticosteroid treatment for relapses, uncertainty remains about most aspects of relapse management. Oral corticosteroids administered by physicians or patients themselves or no corticosteroids also appear justifiable. 5
Research on the role of steroids in the management of brain metastases concluded that steroids are recommended to provide temporary symptomatic relief of symptoms related to increased intracranial pressure and edema secondary to brain metastases. Dexamethasone is the recommended steroid choice. 6
Treatment Summary
Methotrexate was found to be an effective treatment for Crohn's disease, specifically for patients experiencing chronically active Crohn's disease. 1
Inhaled corticosteroids showed efficacy in treating acute asthma, particularly for patients not receiving concomitant systemic steroids. They were found to reduce hospital admission rates in these individuals. 2
Immunosuppressive and cytotoxic therapies for pulmonary sarcoidosis, including methotrexate, chloroquine, cyclosporine A, and pentoxifylline, are used for this condition. However, the evidence supporting their efficacy is limited, and some therapies have been associated with severe side effects. 3 4
High-dose intravenous corticosteroid treatment is recommended for multiple sclerosis relapses. Nevertheless, there is uncertainty surrounding other aspects of relapse management. Oral corticosteroids administered by physicians or patients or no corticosteroids at all may also be valid options. 5
Steroids are recommended for temporary relief of symptoms related to increased intracranial pressure and edema secondary to brain metastases. Dexamethasone is the preferred steroid choice in such instances. 6
Benefits and Risks
Benefit Summary
Methotrexate has been shown to improve symptoms and reduce the need for prednisone in patients with chronically active Crohn's disease. 1
Inhaled corticosteroids have been shown to reduce hospital admission rates in patients with acute asthma who are not receiving concomitant systemic steroids. 2
Steroids are recommended to provide temporary symptomatic relief of symptoms related to increased intracranial pressure and edema secondary to brain metastases. 6
Risk Summary
Methotrexate has been associated with side effects such as asymptomatic elevation of serum aminotransferase and nausea. 1
Immunosuppressive and cytotoxic therapies can have severe side effects. 3 4
Long-term use of steroids comes with various risks. 6
Comparison between Studies
Commonalities in Studies
All studies aimed to evaluate the efficacy and safety of treatments for specific diseases or symptoms.
Differences between Studies
Studies varied in terms of the diseases being studied, the treatments used, the study designs, and the outcomes assessed.
Consistency and Inconsistencies in Findings
These studies provide evidence regarding the efficacy of specific treatments for certain diseases or symptoms. However, not all studies arrive at the same conclusions. For instance, research on the efficacy of immunosuppressive and cytotoxic therapies for pulmonary sarcoidosis found limited evidence supporting their effectiveness, and some therapies were associated with serious side effects. 3 4
Real-World Application Considerations
The findings of these studies offer valuable information to consider when choosing treatments for specific diseases or symptoms. However, it is important to remember that these results may not apply to all individuals. Consulting with a physician and determining the best course of treatment based on individual circumstances is essential.
Limitations of Current Research
Many of these studies were relatively small, and further research is warranted.
Directions for Future Research
Further research is needed to evaluate the efficacy and safety of treatments for these diseases and symptoms in more detail.
Conclusion
These studies provide valuable information regarding the effectiveness of specific treatments for specific diseases and symptoms. However, not all studies reach the same conclusions. When making treatment decisions, it is crucial to consult with a physician and make the best choice based on individual circumstances.
Treatment List
Methotrexate, Inhaled Corticosteroids, Prednisone reduction, Dexamethasone, Chloroquine, Cyclosporine A, Pentoxifylline
Benefit Keywords
Risk Keywords
Article Type
Author: FeaganB G, RochonJ, FedorakR N, IrvineE J, WildG, SutherlandL, SteinhartA H, GreenbergG R, GilliesR, HopkinsM
Language : English
Author: EdmondsM L, CamargoC A, PollackC V, RoweB H
Language : English
Author: ParamothayanS, LassersonT, WaltersE H
Language : English
Author: ParamothayanS, LassersonT J, WaltersE H
Language : English
Author: KöpkeS, KasperJ, MühlhauserI, NüblingM, HeesenC
Language : English
Author: RykenTimothy C, McDermottMichael, RobinsonPaula D, AmmiratiMario, AndrewsDavid W, AsherAnthony L, BurriStuart H, CobbsCharles S, GasparLaurie E, KondziolkaDouglas, LinskeyMark E, LoefflerJay S, MehtaMinesh P, MikkelsenTom, OlsonJeffrey J, PaleologosNina A, PatchellRoy A, KalkanisSteven N
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.